This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David L. Ramsay, MD, MED; Robert E. Parnes, MD; Neil Dubin, PhD

Arch Dermatol. 1984;120(12):1585-1590.

Abstract
• Seventy-six patients with mycosis fungoides (MF) were given topical mechlorethamine hydrochloride therapy. Allergic contact hypersensitivity reactions to the drug developed in 51 patients (67.1%). Sixty-four patients of the original 76 continued therapy, with 43 (67.2%) achieving a complete remission and 12 (18.8%) achieving a partial remission. Stage I disease responded significantly better than did subsequent, more severe disease stages. The median times to complete remission were 5.6 months, 32.3 months, and 22.3 months for stage I, II, and III disease, respectively. The conditions of patients with contact sensitivity did not respond better than those of patients without contact sensitivity. Patients with substage A disease did not respond better than patients with substage B disease. These findings are encouraging and indicate that the use of topically applied mechlorethamine for early-stage MF should be continued, despite the development of contact dermatitis to the drug.

(Arch Dermatol 1984;120:1585-1590)

Author Affiliations
From the Lymphoma Section, Department of Dermatology (Drs Ramsay and Parnes), and the Biostatistics and Epidemiology Laboratory, Department of Environmental Medicine (Dr Dubin), New York University Medical Center.

Footnotes
Accepted for publication Feb 20, 1984.

Reprint requests to New York University Medical Center, 550 First Ave, New York, NY 10016 (Dr Ramsay).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Prospective Study of Cutaneous Intolerance to Topical Mechlorethamine Therapy in Patients With Cutaneous T-Cell Lymphomas
Esteve et al.
Arch Dermatol 1999;135:1349-1353.
ABSTRACT | FULL TEXT  

Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sezary Syndrome: Definition of Three Distinctive Prognostic Groups
Sausville et al.
ANN INTERN MED 1988;109:372-382.
ABSTRACT